Angara: Time to start local studies on vaccination of minors
The local Food and Drug Administration (FDA) should take the cue from its counterparts in the United States and other countries and start studying the use of the available Covid-19 vaccines for children below 18, Sen. Sonny Angara said today.
“In so far as expanding the administration of vaccines to other age groups, we should always be ahead of the curve,” Angara said.
“Greenlighting” certain vaccines for school-age children will address the need of “the largest population group” to be protected from the coronavirus.